Channels - Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV :: FRELIP Discovery

Similar Items: Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV

Quick Look
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
Quick Look
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
Quick Look
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
Quick Look
Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
Quick Look
Pharmacogenetics of Tenofovir (Alafenamide or Disoproxil Fumarate Prodrug) Renal Toxicity in HIV positive Black Southern Africans
Quick Look
Effect of dihydroartemisin-piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV
Quick Look
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
Quick Look
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
Quick Look
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
Quick Look
Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
Quick Look
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
Quick Look
A pharmacokinetic and antimalarial efficacy evaluation of pyridodibemequines and their metabolites
Quick Look
The Development and Validation of a Direct LC-MS/MS Assay for the Determination of Tenofovir-diphosphate in Dried Blood Spots for the Analysis of Clinical Samples
Quick Look
The antiplasmodial, toxicity and pharmacokinetic properties of synthetic derivatives of the natural product Curcumin
Quick Look
Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
Quick Look
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria
Quick Look
Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling
Quick Look
Self-Reported Antenatal Medicines Use Among Women Living with and Without HIV in Western Cape, South Africa: A Sub-Analysis of the B Positive Cohort Study
Quick Look
Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
Quick Look
Antiretroviral therapy adherence and effectiveness in a private sector disease management programme in Southern Africa
Quick Look
Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
Quick Look
Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
Quick Look
Development and validation of liquid chromatography mass spectrometry (L/C/MS/MS) assay for the determination of plasma 4betahydroxycholestrol and cholesterol in HIV infected children in Africa
Quick Look
Efavirenz pharmacogenetics and metabolic toxicity in black South Africans

Author: Sinxadi, Phumla

Author: Cindi, Zinhle Andile

Quick Look
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV